Table 2.
Clinical characteristics of 14 CRC patients included in the study.
| Variable | Nondiabetic (n = 8) | Diabetic (n = 6) | P-value |
|---|---|---|---|
| Age (years, mean ± SD) | 58.13 ± 17.34 | 65.83 ± 14.85 | 0.400 |
| Sex | 0.580 | ||
| Male | 5(62.50%) | 5(83.33%) | |
| Female | 3(37.50%) | 1(16.67%) | |
| BMI (kg/m2, mean ± SD) | 22.85 ± 1.49 | 24.24 ± 1.54 | 0.117 |
| FBG (mmol/l, mean ± SD) | 5.30 ± 0.28 | 7.50 ± 1.03 | < 0.001 |
| Location | 0.538 | ||
| Colon | 7(87.50%) | 4(66.67%) | |
| Rectum | 1(12.50%) | 2(33.33%) | |
| Pathological Differentiation [n (%)] | – | ||
| Moderate | 8(100.00%) | 6(100.00%) | |
| Pathological T category [n (%)] | 0.085 | ||
| T1 | – | 1(16.67%) | |
| T3 | 4(50.00%) | 5(86.33%) | |
| T4 | 4(50.00%) | 0 | |
| Pathological N category [n (%)] | 0.277 | ||
| N0 | 5(62.50%) | 2(33.33%) | |
| N1 | 2(25.00%) | 4(66.67%) | |
| N2 | 1(12.50%) | – | |
| pTNM stage [n (%)] | 0.172 | ||
| I | – | 1(16.67%) | |
| II | 5(62.50%) | 1(16.67%) | |
| III | 3(37.50%) | 4(66.67%) |
CRC colorectal cancer; SD Standard deviation; BMI Body mass index; pTNM pathological tumor-node-metastasis; -, No data